Note 10 - Income Taxes	9 Months Ended
Sep. 30, 2018
Notes to Financial Statements
Income Tax Disclosure [Text Block]	10. Income Taxes The Company routinely evaluates the likelihood of realizing the benefit of its deferred tax assets and may record a valuation allowance if, based on all available evidence, it determines that it is more likely than not some portion of the tax benefit will not be realized. As of September 30, 2018, the Company had an aggregate of approximately $7.9 million in deferred tax assets primarily related to intangible assets, net operating losses, tax credit carryforwards, and inventory basis differences. On a quarterly basis, the Company tests the value of deferred tax assets for impairment at the taxpaying-component level within each tax jurisdiction. Significant judgment and estimates are required in determining whether valuation allowances should be established as well as the amount of such allowances. When making such determination, consideration is given to, among other things, the following: ● sufficient taxable income within the allowed carryback or carryforward periods; ● future reversals of existing taxable temporary differences, including any tax planning strategies that could be utilized; ● nature or character (e.g., ordinary vs. capital) of the deferred tax assets and liabilities; and ● future taxable income exclusive of reversing temporary differences and carryforwards. Based on the foregoing criteria, the Company determined that it no longer meets the “more likely than not” threshold that net operating losses, tax credits and other deferred tax assets will be realized. Accordingly, the Company recorded a full valuation allowance at September 30, 2018. The Company’s forecasted effective tax benefit rate at September 30, 2018 is 0% , as compared to the 10.8% effective tax rate recorded at December 31, 2017. The 10.8% decrease is primarily due to not recognizing benefit in 2018 - Q3 for pre-tax losses and credits, as a result of the Company’s full valuation allowance on net deferred tax assets. The Company recorded discrete tax expense of $6.5M in 2018 - Q3, due primarily to the recording of a full valuation allowance on the Company’s net deferred tax assets.

10.

Income Taxes

The Company routinely evaluates the likelihood of realizing the benefit of its deferred tax assets and

may

record a valuation allowance if, based on all available evidence, it determines that it is more likely than

not

some portion of the tax benefit will

not

be realized. As of

September 30, 2018,

the Company had an aggregate of approximately

$7.9

million in deferred tax assets primarily related to intangible assets, net operating losses, tax credit carryforwards, and inventory basis differences. On a quarterly basis, the Company tests the value of deferred tax assets for impairment at the taxpaying-component level within each tax jurisdiction. Significant judgment and estimates are required in determining whether valuation allowances should be established as well as the amount of such allowances. When making such determination, consideration is given to, among other things, the following:

● sufficient taxable income within the allowed carryback or carryforward periods;

● future reversals of existing taxable temporary differences, including any tax planning strategies that could be utilized;

● nature or character (e.g., ordinary vs. capital) of the deferred tax assets and liabilities; and

● future taxable income exclusive of reversing temporary differences and carryforwards.

Based on the foregoing criteria, the Company determined that it

longer meets the “more likely than

not”

threshold that net operating losses, tax credits and other deferred tax assets will be realized. Accordingly, the Company recorded a full valuation allowance at

September 30, 2018.

The Company’s forecasted effective tax benefit rate at

September 30, 2018

as compared to the

10.8%

effective tax rate recorded at

December 31, 2017.

The

10.8%

decrease is primarily due to

not

recognizing benefit in

2018

for pre-tax losses and credits, as a result of the Company’s full valuation allowance on net deferred tax assets.

The Company recorded discrete tax expense of

$6.5M

2018

Q3,

due primarily to the recording of a full valuation allowance on the Company’s net deferred tax assets.